Open AccessMedication-Related Osteonecrosis of the Jaw and Low-Level Laser Therapy as Adjuvant Treatment: A Case Report
Author(s) -
Amanda Azevedo Torres,
Beatriz Leal de Freitas,
Patrick Parry Carneiro,
André Luca Araújo de Sousa,
Maria Ângela Arêa Leão Ferraz,
Jean de Pinho Mendes,
André Luiz Ferreira Costa,
Antonione Santos Bezerra Pinto
Publication year - 2020
Publication title -
journal of lasers in medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2228-6721
pISSN - 2008-9783
DOI - 10.34172/jlms.2020.78
Subject(s) - medicine , osteonecrosis of the jaw , radiological weapon , adjuvant therapy , low level laser therapy , surgery , photodynamic therapy , lesion , radiation therapy , laser therapy , radiology , chemotherapy , osteoporosis , laser , bisphosphonate , chemistry , physics , organic chemistry , optics
Medication-related osteonecrosis of the jaw (MRONJ) occurs by the use of a drug that has osteonecrosis as one of its side effects. Case Report: We describe a case of a 48-year-old oncological patient who had brain and bone metastasis due to breast cancer and was medicated with bisphosphonates (BPs). She presented cavities, and after an incorrect exodontia, the lesion evolved into a jaw osteonecrosis. Then she did a sequestrectomy and was treated using laser therapy. Radiological and clinical features are also described. Conclusion: In a case like this, we notice how necessary is a complete evaluation of the oncological patient before some procedures and laser therapy as an effective ally in the management.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom